- £688.59m
- £1.21bn
- €1.69bn
- 44
- 44
- 98
- 70
Annual income statement for Renewi, fiscal year end - March 31st, EUR millions except per share, conversion factor applied.
2020 March 31st | R2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,775 | 1,694 | 1,869 | 1,704 | 1,689 |
| Cost of Revenue | |||||
| Gross Profit | 308 | 285 | 357 | 351 | 338 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1,804 | 1,658 | 1,745 | 1,562 | 1,592 |
| Operating Profit | -28.1 | 36.1 | 124 | 142 | 97.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -59.4 | 10.9 | 95.7 | 115 | 60.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -60.5 | 5.5 | 75.4 | 86 | 45.2 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -77.9 | 5.6 | 74.5 | 62.9 | -34.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -77.9 | 5.6 | 74.5 | 62.9 | -34.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.98 | 0.83 | 1.24 | 0.957 | 0.666 |
| Dividends per Share |